100% Secure Payments
Tender Details
- Country: United Kingdom
- Summary: Nhs National Generic Pharmaceuticals Wave 13
- GBT Ref No: 54421758
- Deadline: 26 Jul 2021
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: 710767138
- Notice Type: Tender
- Document Ref. No.: CF-0218500D0O000000rwimUAA1
- Purchaser's Detail :
- Description :
- Title : NHS National Generic Pharmaceuticals Wave 13
Location Of Contract : East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber, Channel Islands, Isle of Man
Industry : Pharmaceutical products - 33600000
Value Of Contract : £710,767,138
Description : Tender Close: 26th July 2021, 13:00.Invitation to offer for NHS National Generic Pharmaceuticals Wave 13Offer reference number: CM/PHG/17/5532Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months.Potential periods of call-offs under the framework agreement:Transition (Everolimus)CESW: 1 March 2022 - 30 September 2023 (19 months)LSNE: 1 March 2022 - 31 January 2023 (11 months)NWLN: 1 March 2022 - 31 January 2023 (11 months)Oral Products plus non-parenteralsAll Regions: 1 March 2022 - 31 May 2024 (27 months)Hospital Only ProductsCESW: 1 February 2022 - 30 September 2023 (20 months)LSNE: 1 February 2022 - 31 May 2024 (28 months)NWLN: 1 February 2022 - 31 January 2023 (12 months)
Published Date : 21 June 2021
Closing Date : 26 July 2021 - Documents :
Purchaser : NHS ENGLAND
2nd Floor Rutland House Runcorn WA7 2ES UK
Contact Person : Gemma Tomlinson / Lynne Tierney
Email :gemma.tomlinson1@nhs.net
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
